- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05763914
A 24-week Single-blind Trial of Prevention of Hand Eczema in Cleaners (HEIC)
September 9, 2023 updated by: Farnam Barati Sedeh, Zealand University Hospital
Hand Eczema in Cleaners: a Randomized Clinical Trial of Picture-based Prevention Compared to Treatment as Usual Among Professional Hospital Cleaners
This study aims to investigate the effectiveness of picture-based prevention education among professional hospital cleaners in relation to hand eczema.
This is a single-blinded randomized clinical trial including hospital cleaners at three different hospitals.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
- Behavioral: Change in the incidence of hand eczema
- Behavioral: Change in severity of hand eczema
- Behavioral: Change in the number of self-reported days with absence from work due to having hand eczema
- Behavioral: Change in the number of participants being forced to change their job due to having hand eczema
- Behavioral: Change in The Quality Of Life in in relation to hand eczema
- Behavioral: Change in the level of knowledge regarding skin care and protection.
Study Type
Interventional
Enrollment (Actual)
234
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zealand Region
-
Køge, Zealand Region, Denmark
- Cleaning departments at Køge, Slagelse and Holbæk hospitals
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Professional hospital cleaners ≥ 18 years old
- Sufficient Danish skills
- Written informed consent
Exclusion Criteria:
- Insufficient Danish skills
- Pregnancy
- Other skin diseases on the hands
- Receiving Immunomodulatory therapies
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1: Picture-based prevention education and an educational course
The participants will have access to picture-based prevention education, and at the same time, they will participate in an educational course.
|
Assessed by the self-reported cases of newly-developed hand eczema.
Change between baseline and 6 months.
Assessed by using the Hand Eczema Severity Index (HECSI).
HECSI score: 0-360 points (0 best, 360 worst).
Change between baseline and 6 months.
Self-reported total number of sick days due to having hand eczema.
Change between baseline and 6 months.
Self-reported change of job due to having hand eczema.
Change between baseline and 6 months.
Assessed by using Hand Eczema Questionnaire (QolHEQ).
Change between baseline and 6 months.
Self-reported level of knowledge regarding skin care and protection.
Change between baseline and 6 months.
|
|
Experimental: Group 2: Picture-based prevention education only (no educational course)
The participants will only have access to picture-based prevention education and will not participate in any educational course.
|
Assessed by the self-reported cases of newly-developed hand eczema.
Change between baseline and 6 months.
Assessed by using the Hand Eczema Severity Index (HECSI).
HECSI score: 0-360 points (0 best, 360 worst).
Change between baseline and 6 months.
Self-reported total number of sick days due to having hand eczema.
Change between baseline and 6 months.
Self-reported change of job due to having hand eczema.
Change between baseline and 6 months.
Assessed by using Hand Eczema Questionnaire (QolHEQ).
Change between baseline and 6 months.
Self-reported level of knowledge regarding skin care and protection.
Change between baseline and 6 months.
|
|
Placebo Comparator: Group 3: Placebo (control)
The participants will not have access to picture-based prevention education and do not participate in any educational course.
|
Assessed by the self-reported cases of newly-developed hand eczema.
Change between baseline and 6 months.
Assessed by using the Hand Eczema Severity Index (HECSI).
HECSI score: 0-360 points (0 best, 360 worst).
Change between baseline and 6 months.
Self-reported total number of sick days due to having hand eczema.
Change between baseline and 6 months.
Self-reported change of job due to having hand eczema.
Change between baseline and 6 months.
Assessed by using Hand Eczema Questionnaire (QolHEQ).
Change between baseline and 6 months.
Self-reported level of knowledge regarding skin care and protection.
Change between baseline and 6 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence rate of hand eczema
Time Frame: Change between baseline and 6 months
|
Measured by a self-reported questionnaire
|
Change between baseline and 6 months
|
|
Hand Eczema Severity Index (HECSI)
Time Frame: Change between baseline and 6 months
|
Objective assessment of disease severity, measured by HECSI-score: 0-360 points (0 best, 360) worst)
|
Change between baseline and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of absence from work due to having hand eczema
Time Frame: Change between baseline and 6 months
|
Measured by a self-reported questionnaire
|
Change between baseline and 6 months
|
|
Rate of participants being forced to change their job due to having hand eczema (questionnaire-based).
Time Frame: Change between baseline and 6 months
|
Measured by a self-reported questionnaire
|
Change between baseline and 6 months
|
|
The Quality Of Life in Hand Eczema Questionnaire (QqlHEQ)
Time Frame: Change between baseline and 6 months
|
Subjective assessment of quality of life using QqlHEQ which contains 30 items; generally, all items are scored 0-4 (only three items differ in their scoring structure).
|
Change between baseline and 6 months
|
|
Rate of knowledge regarding skin care and protection.
Time Frame: Change between baseline and 6 months
|
Measured by a self-reported questionnaire
|
Change between baseline and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kristina Sophie Ibler, M.D., Zealand University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 14, 2022
Primary Completion (Actual)
June 24, 2023
Study Completion (Actual)
June 24, 2023
Study Registration Dates
First Submitted
February 14, 2023
First Submitted That Met QC Criteria
March 8, 2023
First Posted (Actual)
March 10, 2023
Study Record Updates
Last Update Posted (Actual)
September 13, 2023
Last Update Submitted That Met QC Criteria
September 9, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20205100702
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The results of the project will be shared with other researchers.
IPD Sharing Time Frame
Materials will be made available six months after the publication of the primary outcomes.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hand Eczema
-
CorEvitasNot yet recruiting
-
LEO PharmaICON Clinical Research; IQVIA Inc.; Optimapharm; Vivactis M2ResearchEnrolling by invitationChronic Hand Eczema (CHE)Germany
-
University Hospital, Gentofte, CopenhagenTrygFonden, DenmarkCompletedChronic Hand Dermatitis | Chronic Hand EczemaDenmark
-
Cosmetique Active InternationalCompleted
-
University Hospital Bispebjerg and FrederiksbergStatens Serum InstitutRecruiting
-
BayerCompleted
-
Bispebjerg HospitalUniversity of Copenhagen; LEO Foundation; Government of Greenland, Agency for... and other collaboratorsActive, not recruitingHand EczemaGreenland
-
Incyte CorporationCompletedHand EczemaUnited States, Poland, Canada, Germany
-
Incyte CorporationWithdrawnHand EczemaUnited States, Germany, Spain, Czechia, Canada, Poland
Clinical Trials on Change in the incidence of hand eczema
-
Centre Hospitalier Universitaire, AmiensUnknownEmergencies | Cognitive Impairment | Cerebral SaturationFrance
-
Hospices Civils de LyonRecruiting
-
Hull University Teaching Hospitals NHS TrustNational Institute for Health Research, United Kingdom; University of York; South... and other collaboratorsCompletedCoronary Artery Disease | Quality of LifeUnited Kingdom
-
Clinica Universidad de Navarra, Universidad de...Not yet recruitingCervical Cancer Screening | HPV Vaccination
-
Military Institute of Medicine, PolandCompleted
-
University of Medicine and Pharmacy at Ho Chi Minh...UnknownIncidence of Delirium in Inpatient Elderly PatientsVietnam
-
Hasan Kalyoncu UniversityWithdrawnCarpal Tunnel Syndrome
-
Instituto Nacional de Ciencias Medicas y Nutricion...National Council of Science and Technology, MexicoCompleted
-
Center of Implantology, Oral and Maxillofacial...Universitat Internacional de CatalunyaCompletedPeriodontal Disease | PeriimplantitisSpain
-
Centre Hospitalier Universitaire de Saint EtienneCompleted